News & Views

  • Medical Diagnostics Joint Venture

Medical Diagnostics Joint Venture

Apr 01 2011 Read 1277 Times

The University of Birmingham and medical diagnostics specialists, Abingdon Health Ltd, have launched Bioscience Ventures Ltd (‘Bioscience Ventures’), a new joint initiative aimed at developing and marketing new diagnostics products for the healthcare and other industries.

Biosciences Ventures will focus on developing new diagnostic tools for conditions where there are currently unmet needs in the market such as various forms of cancer, genetic related diseases and platform technologies with applications in many areas of medicine including infectious disease testing, drug testing and veterinary applications utilising intellectual property developed at the
University of Birmingham.

Operating from the University’s campus in Edgbaston, and through its established trading subsidiary company, Alta Bioscience Ltd, Bioscience Ventures will also provide a variety of services such as analysis and synthesis of DNA, protein and other biochemicals to clients both on and off campus in the pharmaceutical and food industries.

The new joint venture will be led by Executive Chairman, Dr Chris Hand, who was former Chief Executive of medical diagnosticscompany, Cozart plc.


Digital Edition

International Labmate February 2021

February 2021

In This Edition Articles - Expanding the Boundaries of Light Scattering for Macromolecules - Electrostatic Charges and Their Effects on Weighing - How the world’s most advanced analytical...

View all digital editions

Events

SIAF Guangzhou

Mar 03 2021 Guanghzou, China

PITTCON 2021

Mar 08 2021 Virtual Event

Bio-Europe Spring

Mar 22 2021 Digital event

Medtec Japan 2021

Apr 14 2021 Tokyo, Japan

MedtecLIVE

Apr 20 2021 Virtual event

View all events